AgomAb Therapeutics N.V. American Depositary Shares
(AGMB - NASDAQ)
15,78 USD
📋 Profilo Aziendale

AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies.

|